
PAI-1
Il Plasminogen Activator Inhibitor-1 (PAI-1) è un inibitore delle serin proteasi che regola la fibrinolisi inibendo l'attivatore tissutale del plasminogeno (tPA) e l'urochinasi (uPA). Livelli elevati di PAI-1 sono associati a un aumento del rischio di trombosi, malattie cardiovascolari e sindrome metabolica. Gli inibitori di PAI-1 sono oggetto di ricerca per il loro potenziale nel trattamento di queste condizioni. Presso CymitQuimica, offriamo inibitori di PAI-1 per supportare la tua ricerca in ematologia, salute cardiovascolare e malattie metaboliche.
Trovati 26 prodotti di "PAI-1"
Ordinare per
Purezza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Upamostat
CAS:Upamostat is an inhibitor of a serine protease and is a urokinase plasminogen activator (uPA) inhibitor.Formula:C32H47N5O6SPurezza:99.41%Colore e forma:SolidPeso molecolare:629.81Angstrom6
CAS:<p>Angstrom6 (A-6 peptide) is an 8 amino acid peptide derived from single chain urokinase fibrinogen activator (scuPA) that interferes with the uPA/uPAR cascade</p>Formula:C39H62N10O15Purezza:99.36%Colore e forma:SolidPeso molecolare:910.97CT140
<p>CT140 is a human IgG4 monoclonal antibody (mAb) that specifically targets PAI-1. The suggested isotype control for this compound is Human IgG4 kappa, Isotype Control.</p>Colore e forma:Odour LiquidGGACK hydrochloride
<p>GGACK (H-Glu-Gly-Arg-CMK) hydrochloride is an irreversible substrate-like inhibitor of the serine protease urokinase-type plasminogen activator (uPA).</p>Formula:C14H26Cl2N6O5Colore e forma:SolidPeso molecolare:428.13417Nattokinase
CAS:Nattokinase is a serine protease derived from nattō, oral, fibrinolytic/anticoagulant properties. It degrades fibrin, fibrinolytic substrates, and PAI-1.Colore e forma:SolidUK140
<p>UK140 is an inhibitor of the urokinase-type plasminogen activator (uPA), with Ki values of 0.20 µM for human uPA (huPA) and 2.79 µM for mouse uPA (muPA). UK140 is applicable in studies related to tumor metastasis.</p>Formula:C72H105N19O25S3Colore e forma:SolidPeso molecolare:1732.91Bicyclic UK18
CAS:Bicyclic UK18 is a competitive inhibitor of human urokinase-type plasminogen activator (uPA) with a Ki value of 53 nM.Formula:C77H118N26O25S3Colore e forma:SolidPeso molecolare:1904.116-Aminocaproic acid (Standard)
CAS:6-Aminocaproic acid (Standard) is the standard substance of 6-Aminocaproic acid, and it is applicable for quantitative analysis, quality control, and related research in biochemical experiments. 6-Aminocaproic acid (EACA) is an antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.Formula:C6H13NO2Colore e forma:Fine White Crystalline Powder SolidPeso molecolare:131.17Loureirin B
CAS:Loureirin B suppresses fibrosis by modulating MMPs/TIMPs, hindering fibroblast growth, and targeting TGF-β1/Smad2/3 pathway.Formula:C18H20O5Purezza:99.33% - 99.86%Colore e forma:SolidPeso molecolare:316.35TM5441
CAS:<p>TM5441 is an orally bioavailable fibrinogen activator inhibitor-1 inhibitor that inhibits several cancer cell lines with IC50 values ranging from 13.9 to 51.1 μM.Cost-effective and quality-assured.Cost-effective and quality-assured.</p>Formula:C21H17ClN2O6Purezza:97.62% - 99.09%Colore e forma:SolidPeso molecolare:428.82Tiplaxtinin
CAS:<p>Tiplaxtinin (Tiplasinin)(PAI-039) is a selective and orally efficacious inhibitor of plasminogen activator inhibitor-1 (PAI-1) with IC50 of 2.7 uM.</p>Formula:C24H16F3NO4Purezza:99.16% - 99.93%Colore e forma:SolidPeso molecolare:439.38Toddalolactone
CAS:Toddalolactone ((+)-Toddalolactone) is an anti-inflammatory and analgesic.Formula:C16H20O6Purezza:99.8% - 99.85%Colore e forma:SolidPeso molecolare:308.33TM5275 sodium
CAS:TM5275 sodium (TM5275 sodium salt) is an inhibitor of plasminogen activator inhibitor 1 (PAI-1).Formula:C28H27ClN3NaO5Purezza:98.8% - 99.74%Colore e forma:SolidPeso molecolare:543.98TM5007
CAS:TM5007 is a poent inhibitor of plasminogen activator inhibitor-1 (PAI-1; IC50 of 29 uM).Formula:C24H20N2O6S4Purezza:96.91%Colore e forma:SolidPeso molecolare:560.69UK-371804
CAS:UK-371804: potent uPA blocker; candidate for chronic skin ulcer preclinical studies.Formula:C14H16ClN5O4SPurezza:95.81% - 99.77%Colore e forma:SolidPeso molecolare:385.83MDI-2268
CAS:MDI-2268, an inhibitor of plasma kallikrein inhibitor 1 (PAI-1), exhibits strong antithrombotic properties. It plays a role in regulating blood coagulation by promoting fibrinolysis and is applicable in research related to deep vein thrombosis.Formula:C10H10F3N3O3Colore e forma:SolidPeso molecolare:277.20SK-216
CAS:SK-216,PAI-1 inhibitor. Reduces tumor angiogenesis. Inhibits VEGF-induced endothelial cell migration. Alleviates pulmonary fibrosis.Formula:C29H29NNa2O6Purezza:98.29%Colore e forma:SolidPeso molecolare:533.52UK-371804 HCl
CAS:UK-371804 is a potent and selective urokinase-type plasmogen activator (uPA) inhibitor with excellent enzyme potency (Ki=10 nM) and selectivity profile (2700-Formula:C14H17Cl2N5O4SPurezza:98%Colore e forma:SolidPeso molecolare:422.29Diaplasinin
CAS:Diaplasinin (PAI-749) is a potent inhibitor of plasminogen activator inhibitor-1 (PAI-1) with antithrombotic activity, used in cardiovascular disease research.Formula:C32H31N5OPurezza:99.02%Colore e forma:SolidPeso molecolare:501.62Aleplasinin
CAS:Aleplasinin (PAZ 417) is a selective and orally active inhibitor of Plasminogen activator inhibitor-1(PAI-1) and a key negative regulator of the fibrinolyticFormula:C28H27NO3Purezza:99.21%Colore e forma:SolidPeso molecolare:425.52

